http://www.xendo.comNewsXendo B.V.beheer@grip.nl2008-06-25T17:00:37+02:00http://www.xendo.com/news/5559/ Medische Technologie meets Life ScienceMedical Delta Cafe: Medische Technologie meets Life Science.
Wat is de toegevoegde waarde van medische technologie voor de life science en welke wet- en regelgeving komt er kijken bij de ontwikkeling en marktintroductie van een medisch-technologisch product?
Rutger Kuipers van Xendo spreekt hierover.2010-08-16T12:30:00+02:00http://www.xendo.com/news/5554/QPS Announces the Acquisition of Xendo Drug Development2010-07-26T18:00:00+02:00http://www.xendo.com/news/5376/Xendo Drug Development, a leading position in (LC-)ICP-MS bioanalysis for over 7 years2010-06-02T11:30:00+02:00http://www.xendo.com/news/5497/Xendo announces Partnership with QPS 2010-04-14T12:30:00+02:00http://www.xendo.com/news/5493/Xendo completes clinical part of Phase I study with DBS2010-04-13T10:00:00+02:00http://www.xendo.com/news/5389/Xendo Drug Development is introducing UHPLC in the bioanalytical laboratories2010-03-11T16:30:00+01:00http://www.xendo.com/news/5370/Phase I study with Dried Blood Spot technology for clinical sampling and bioanalysis2010-02-01T12:30:00+01:00http://www.xendo.com/news/5083/high-throughput screening for culture medium optimization2009-05-16T08:30:00+02:00http://www.xendo.com/news/5008/Strengere controle gezondheidszorg door IGZ / Dutch inspection tightens control2009-03-25T14:00:00+01:00http://www.xendo.com/news/5007/New organization chart for Xendo2009-01-01T13:00:00+01:00http://www.xendo.com/news/4871/Xendo's Integrated Drug Development concept accelerates biopharmaceutical development projects2008-11-24T17:00:00+01:00http://www.xendo.com/news/4793/Immulite 2000 Analyzer2008-10-31T14:00:00+01:00http://www.xendo.com/news/4668/Immunogenicity analysis and multiplex biomarker assays with new ECL equipment at Xendo2008-07-29T15:00:00+02:00http://www.xendo.com/news/4153/Full clinical research services now offered2007-12-21T08:30:00+01:00http://www.xendo.com/news/3858/Xendo's Bioanalysis and Drug Metabolism introduces new LIMS2007-11-06T15:00:00+01:00http://www.xendo.com/news/3760/Disposables Reach Out to New Markets2007-10-08T09:00:00+02:00http://www.xendo.com/news/3631/TI Pharma project on metabolic stability of NCE's takes off2007-09-17T14:00:00+02:00http://www.xendo.com/news/3610/Xendo joins the Ride for the Roses2007-09-07T10:30:00+02:00http://www.xendo.com/news/3607/Xendo CTM's director interviewed by C2WInterview with Ard Tijsterman, Managing Director of Xendo Clinical Trial Material2007-08-31T13:30:00+02:00http://www.xendo.com/news/3299/New Managing Director in DenmarkAs of the 1st of June 2007, Xendo Pharma Service A/S in Denmark has appointed Klaus Snej Jensen, as new Managing Director. Klaus will focus on the further development of the Xendo consulting capabilities in Medicon Valley as well as the general management of the Danish Division.2007-06-21T12:00:00+02:00http://www.xendo.com/news/3228/The bisphosphonates bioanalytical challenge – Xendo’s answer: the risedronate caseThe bisphosphonates bioanalytical challenge – Xendo’s answer: the risedronate case
2007-05-07T13:30:00+02:00http://www.xendo.com/news/3182/Focus Scandinavian activities2007-04-25T10:00:00+02:00http://www.xendo.com/news/3091/Xendo CTM, a new life science company in The NetherlandsCMO for low cost GMP manufacturing of recombinant proteins and monoclonal antibodies for phase I and phase II clinical trials2007-04-05T08:30:00+02:00http://www.xendo.com/news/2859/Business Management services expanded2007-03-26T20:30:00+02:00http://www.xendo.com/news/2839/Clinical pharmacology of chiral compounds – an expertise of XendoXendo Drug Development B.V. is a leading participant within the Ultimate Chiral Technologies consortium (UCT). This consortium focuses on further developing expertise in chiral science and technology, in combination with DSM Pharma Chemicals, Syncom and two major Dutch Universities (Groningen and Nijmegen).2007-03-19T16:30:00+01:00http://www.xendo.com/news/2780/GMP status van Nederlandse ziekenhuizen2007-03-09T00:00:00+01:00http://www.xendo.com/news/2528/Xendo Newsletter special edition on bioanalysis and biomarkers - out now!2007-01-10T00:00:00+01:00http://www.xendo.com/news/2526/Xendo conducts human microdosing (human phase 0) study for Biofrontera AG2007-01-10T00:00:00+01:00http://www.xendo.com/news/2495/On-line clinical studies – LPS challenge testing2006-12-22T00:00:00+01:00http://www.xendo.com/news/1177/On-line clinical studies – full integration of CPrU and bioanalysis2006-12-04T00:00:00+01:00http://www.xendo.com/news/731/Biotech News interview with Koos Koops and Ard Tijsterman2006-11-15T00:00:00+01:00http://www.xendo.com/news/721/Xendo partner in Top Institute Pharma2006-11-15T00:00:00+01:00